WO2001022915A2 - Process for production of cis-dichloro-(trans-1-1,2-cyclohexanediamine)platinum(ii) - Google Patents
Process for production of cis-dichloro-(trans-1-1,2-cyclohexanediamine)platinum(ii) Download PDFInfo
- Publication number
- WO2001022915A2 WO2001022915A2 PCT/CZ2000/000070 CZ0000070W WO0122915A2 WO 2001022915 A2 WO2001022915 A2 WO 2001022915A2 CZ 0000070 W CZ0000070 W CZ 0000070W WO 0122915 A2 WO0122915 A2 WO 0122915A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- alkali metal
- tetrachloroplatinate
- aqueous solution
- trans
- platinum
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 17
- HRGDZIGMBDGFTC-UHFFFAOYSA-N platinum(2+) Chemical compound [Pt+2] HRGDZIGMBDGFTC-UHFFFAOYSA-N 0.000 title claims abstract description 14
- 238000004519 manufacturing process Methods 0.000 title abstract description 7
- 239000007864 aqueous solution Substances 0.000 claims abstract description 15
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims abstract description 14
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 13
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims abstract description 13
- 229940095064 tartrate Drugs 0.000 claims abstract description 13
- 150000001340 alkali metals Chemical class 0.000 claims abstract description 11
- 239000011541 reaction mixture Substances 0.000 claims abstract description 7
- 238000000926 separation method Methods 0.000 claims abstract description 7
- 239000012431 aqueous reaction media Substances 0.000 claims abstract description 3
- 239000012265 solid product Substances 0.000 claims abstract description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 15
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 14
- 229910052700 potassium Inorganic materials 0.000 claims description 14
- 239000011591 potassium Substances 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 10
- 238000007792 addition Methods 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000007900 aqueous suspension Substances 0.000 claims description 3
- LIAWOTKNAVAKCX-UHFFFAOYSA-N hydrazine;dihydrochloride Chemical compound Cl.Cl.NN LIAWOTKNAVAKCX-UHFFFAOYSA-N 0.000 claims description 3
- 238000006386 neutralization reaction Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 230000021962 pH elevation Effects 0.000 claims description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 4
- -1 alkali metal salt Chemical class 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000012429 reaction media Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- SSJXIUAHEKJCMH-WDSKDSINSA-N (1s,2s)-cyclohexane-1,2-diamine Chemical compound N[C@H]1CCCC[C@@H]1N SSJXIUAHEKJCMH-WDSKDSINSA-N 0.000 description 1
- 239000001358 L(+)-tartaric acid Substances 0.000 description 1
- 235000011002 L(+)-tartaric acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-LWMBPPNESA-N L-(+)-Tartaric acid Natural products OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 description 1
- 229910019032 PtCl2 Inorganic materials 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- SSJXIUAHEKJCMH-UHFFFAOYSA-N cyclohexane-1,2-diamine Chemical compound NC1CCCCC1N SSJXIUAHEKJCMH-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 description 1
- 229960001756 oxaliplatin Drugs 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010977 unit operation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
Definitions
- the invention deals with a new process for production of an antitumor effective compound c/5-dichloro-(tr ⁇ «5-/-l,2-cyclohexanediamine)platinum(II) complex of the formula
- the goal of the present invention is to find a new process for preparation of the cis- dichloro-(tra «5-/-l,2-cyclohexanediamine)platinum(II) which would not suffer from the above disadvantages.
- 1 molar equivalent of an alkali metal salt of tetrachloroplatinate(II) is treated with 1.1 to 1.3 molar equivalents of tr «5-/-l,2-cyclohexanediammonium tartrate.
- the alkalinity of the reaction mixture is maintained during the reaction by additions of an alkali metal hydroxide within the pH range from 8 to 11.
- the aqueous suspension of tr ⁇ «s-/-l,2-cyclohexanediammonium tartrate is first alkalinized by an alkali metal hydroxide to a pH value higher than 8 and , prior to mixing with the aqueous solution of alkali metal tetrachloroplatinate(II), the obtained solution is separated from insoluble impurities present.
- a raw aqueous solution of potassium tetrachloroplatinate(II) obtained by reduction of potassium hexachloroplatinate(IV) by hydrazinium dichloride, separation of insoluble parts and neutralisation of the free hydrochloric acid present in the obtained aqueous solution by an alkali metal hydroxide may advantageously be used .
- Reaction temperature is not a critical parameter within the process of the invention.
- the obtained c/s-dicMoro-(tr ⁇ «s-/-l,2-cyclohexanediamine)platinum(II) may be separated from the reaction mixture by standard separation techniques, washed with a diluted hydrochloric acid and/or by water and/or by a water miscible organic solvent, advantageously by a low boiling alcohol, and optionally also by ether, and subsequently dried.
- the optically active tr ⁇ «5-/-l,2-cyclohexanediammonium tartrate may be prepared in advance by reaction of tr ⁇ ws- 1,2-cyclohexanediamine with L(+)-tartaric acid, wherein it is not necessary to convert the said product to traws-/-l,2-cyclohexanediamine by an otherwise difficult process which is very sensitive to the presence of even trace amounts of the air (decomposition of the tartrate, extraction of the liberated free diamine by an organic solvent, removal thereof by distillation and distillation of trans-l-l,2-cyclo- hexanediamine in vacuo ).
- the trans-/- 1,2-cyclohexanediarnmonium tartrate may, prior to the reaction with alkali metal tetrachloroplatinate(II) , be made free from present insoluble impurities by such a way that its aqueous suspension is made alkaline by an alkali metal hydroxide to pH value of at least 8 and the obtained solution is brought into the reaction after separation of impurities.
- Another advantage of the process for production of c/s-dichloro-(traws-/-l,2-cyclo- hexanediamine)platinum(II) according to the invention is based on the possibility to use a raw solution of potassium tetrachloroplatinate(II) obtained by reduction of potassium hexachloroplatinate(IV) with hydrazinium dichloride, removing insoluble matter and neutralisation of free hydrochloric acid by an alkali metal hydroxide, in the place of the solution of an alkali metal tetrachloroplatinate(II).
- pH value of the reaction mixture was maintained at 9.5-10.0 by addition of approx. 2M solution of potassium hydroxide via a peristaltic pump.
- the yield was 58.1 g of c s-dichloro-(tr ns-/-l,2-cyclohexanediamine)platinum(II), i.e. 97.6% of theoretical yield, based on the starting potassium tetrachloroplatinate(II).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU72673/00A AU7267300A (en) | 1999-09-29 | 2000-09-22 | Process for production of cis-dichloro-(trans-1-1,2-cyclohexanediamine)platinum(ii) |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZPV1999-3458 | 1999-09-29 | ||
CZ19993458A CZ294382B6 (en) | 1999-09-29 | 1999-09-29 | Process for preparing cis-dichloro-(trans-l-1,2-cyclohexanediamine)platinum complex |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001022915A2 true WO2001022915A2 (en) | 2001-04-05 |
WO2001022915A3 WO2001022915A3 (en) | 2001-10-25 |
Family
ID=5466775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CZ2000/000070 WO2001022915A2 (en) | 1999-09-29 | 2000-09-22 | Process for production of cis-dichloro-(trans-1-1,2-cyclohexanediamine)platinum(ii) |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU7267300A (en) |
CZ (1) | CZ294382B6 (en) |
WO (1) | WO2001022915A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104940151A (en) * | 2015-07-23 | 2015-09-30 | 青岛蓝盛洋医药生物科技有限责任公司 | Oxaliplatin freeze-dried powder injection composition as anti-cancer drug |
CN104945443A (en) * | 2015-07-23 | 2015-09-30 | 青岛蓝盛洋医药生物科技有限责任公司 | Drug, namely oxaliplatin compound, for treating cancer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2558469B1 (en) * | 1984-01-25 | 1986-06-27 | Bellon Labor Sa Roger | NOVEL PLATINUM COORDINATION COMPOUNDS, METHODS OF MAKING SAME AND THEIR USE AS MEDICAMENTS |
IL74449A (en) * | 1984-03-01 | 1988-07-31 | Us Commerce | Tetrahalo-1,2-cyclohexane-diamino platinum complexes and anti-neoplastic compositions comprising them |
US4658047A (en) * | 1985-09-27 | 1987-04-14 | The United States Of America As Represented By The Department Of Health And Human Services | Method of preparing 1,2-diaminocyclohexane tetrachloro platinum (IV) isomers |
JP2820289B2 (en) * | 1989-10-13 | 1998-11-05 | 田中貴金属工業株式会社 | Method for producing potassium tetrachloroplatinate |
-
1999
- 1999-09-29 CZ CZ19993458A patent/CZ294382B6/en not_active IP Right Cessation
-
2000
- 2000-09-22 AU AU72673/00A patent/AU7267300A/en not_active Abandoned
- 2000-09-22 WO PCT/CZ2000/000070 patent/WO2001022915A2/en active Application Filing
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104940151A (en) * | 2015-07-23 | 2015-09-30 | 青岛蓝盛洋医药生物科技有限责任公司 | Oxaliplatin freeze-dried powder injection composition as anti-cancer drug |
CN104945443A (en) * | 2015-07-23 | 2015-09-30 | 青岛蓝盛洋医药生物科技有限责任公司 | Drug, namely oxaliplatin compound, for treating cancer |
Also Published As
Publication number | Publication date |
---|---|
WO2001022915A3 (en) | 2001-10-25 |
AU7267300A (en) | 2001-04-30 |
CZ9903458A3 (en) | 2001-05-16 |
CZ294382B6 (en) | 2004-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7956208B2 (en) | Preparation of platinum (II) complexes | |
US7888523B2 (en) | Preparation of platinum(II) complexes | |
CN100408588C (en) | Oxaliplatin with low content of associated impurities and preparation method thereof | |
US7888390B2 (en) | Preparation of platinum(II) complexes | |
JPH09278785A (en) | Method for producing platinum compound | |
WO2001022915A2 (en) | Process for production of cis-dichloro-(trans-1-1,2-cyclohexanediamine)platinum(ii) | |
US7208616B2 (en) | Cis-diiodo-(trans-L-1,2-cyclohexanediamine) platinum (II) complex and processes for preparing high purity oxaliplatin | |
JP3859093B2 (en) | Method for producing antitumor platinum complex carboplatin | |
JP4568400B2 (en) | Method for producing 5,5'-bi-1H-tetrazole diammonium salt using hydrated hydrazine and dicyan as raw materials | |
RU2186068C2 (en) | Method of purification of cis-dichloroamminiso-propylaminplatinum (ii) | |
RU2457838C1 (en) | Method of obtaining trans-1,2-diaminocyclohexane tetrachloroplatinum (iv) | |
JPH0725539B2 (en) | Method for producing dicyanamide metal salt | |
US4800072A (en) | Anhydrous cerous nitrate-ammonium nitrate complex and a process for its preparation from ceric ammonium nitrate | |
US20020099159A1 (en) | Method of synthesizing complexes of platinum and alkenylpolysiloxane, especially of platinum and divinyltetramethyldisiloxane | |
HU199478B (en) | Process for producing 1-square brackets open amino-iso (benzofuranonyl) square brackets closed isoquinoline derivatives | |
JP2537204B2 (en) | Method for producing hydantoins | |
JPH07278120A (en) | Process for producing 5-formylamino-pyrimidine | |
KR100197112B1 (en) | Process for the prepararing tetrahydro amino acridine and their hydrocloride salts | |
JPH0827151A (en) | Pudding manufacturing method | |
JPS62258340A (en) | Production of solid disodium p-hydroxybenzoate | |
HU211283A9 (en) | Highly pure amidoximes | |
JP2002105068A (en) | Method for producing sulfoalkylating agent | |
JPS61165387A (en) | Production of aminated phthalide-quinoline compound | |
JPS61233685A (en) | Production of aminated phthalide-isoquinoline |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |